- Home
- AMTD vs MNOV Comparison
AMTD vs MNOV Comparison
Compare AMTD & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMTD | MNOV |
|---|---|---|
| Founded | 2003 | 2000 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.2M | 72.7M |
| IPO Year | 2019 | 2004 |
Fundamental Metrics
Financial Performance| Metric | AMTD | MNOV |
|---|---|---|
| Price | $1.02 | $1.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 33.5K | ★ 58.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,360,807.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.31 | ★ N/A |
| Revenue Growth | N/A | ★ 194.15 |
| 52 Week Low | $0.87 | $1.13 |
| 52 Week High | $1.65 | $1.96 |
Technical Indicators
Market Signals| Indicator | AMTD | MNOV |
|---|---|---|
| Relative Strength Index (RSI) | 56.05 | 36.57 |
| Support Level | $0.98 | $1.23 |
| Resistance Level | $1.05 | $1.38 |
| Average True Range (ATR) | 0.04 | 0.10 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 90.09 | 6.41 |
Price Performance
Historical ComparisonAbout AMTD AMTD IDEA Group each representing six (6)
AMTD IDEA Group is a financial institution operating in five business segments: The capital market solutions segment assists customers in raising funds through equity and debt financing, private placements, and debt issuances. The digital solutions and other services segment provides institutional and corporate clients with paid access to enhance investor communication and relations, corporate communication also provides digital financial solution services. The Media and entertainment segment offers print and digital advertising campaigns, licensing, and marketing services including branded content, video production. The hotel operations, hospitality, and VIP services segment engages in hotel investments, hotel operations, hospitality, and VIP services; and Strategic investment segment.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.